Myomectomy Operation and Fundus Incision, Energy Modalities and Methods of Extraction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-01

Study Completion Date

2022-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Myomectomy operation due to myoma uteri is an operation that can cause serious blood loss. For some anatomical reasons, fundal myomas were removed, while a group of investigators recommended the initiation of a longitudinal incision and some surgeons preferred a transverse incision. the authors aim to show some surgical differences, intraoperative blood loss, and difficulties and ease of removal of myoma in patients with these approaches without consensus. It is also noted that the incision made with the same energy modality is recorded; The effect of energy modality on blood loss and surgical comfort will be examined. Different approaches are used for laparoscopic surgical operations in order to remove myoma from the abdomen. It can be removed from the vagina by colpotomy and can also be minimized in the abdomen by a morselator. In particular, patients with vaginal myoma removed, such as complaints of postoperative dyspareunia will be followed. In this way, the investigators aim to evaluate the methods which have not yet gained clarity in the literature or have not proven superiority to each other.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transverse vs Longitudinal Incision in Myomectomy

NCT03009812

Myoma;Uterus

COMPLETED NA

Uterine Tourniquet at Open Myomectomy

NCT02049242

Myomectomy Uterine Leiomyoma

COMPLETED NA

Myomectomies:Tumor Characteristics and Clinical Implications

NCT02671253

Uterine Myomectomy Genetics Quality of Life +1 more

UNKNOWN

Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy

NCT03308643

Myomectomy

COMPLETED PHASE4

Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping

NCT07200778

Laparoscopic Myomectomy

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myoma;Uterus Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myomectomy Operation

Patients undergoing myomectomy for myoma uteri

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients operated with the diagnosis of myoma uteri

Exclusion Criteria

* Cardiopulmonary diseases such as cardiac insufficiency, myocardial infarction, unstable angina, acute or new vascular thrombosis, asthma or pulmonary obstructive disease;
* Patients with long-term Trendelenburg contraindications;
* Previous pelvic or abdominal radiation therapy; or those with inadequate bone marrow, kidney and hepatic function;
* Gynecological malignancies.
* Those who received preoperative medication due to myoma uteri

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No